understanding the pathway: barriers to data collection and onward referral to specialist hepatitis c...
TRANSCRIPT
![Page 1: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/1.jpg)
Understanding the pathway: barriers to data collection and onward referral to specialist
hepatitis C services for PWUD in London
![Page 2: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/2.jpg)
2013 LJWG pilot projects • LJWG London Consensus 2011 set out clear
recommendations
• assess the impact of the recommendations
• measured rates of testing, diagnosis and referral
• data collection proves challenging
![Page 3: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/3.jpg)
2013 LJWG pilot projects • no funding, resources provided on a goodwill
basis • variation in existing service provision across
the sites • interim findings suggest positive impact on the
number of patients diagnosed and referred
![Page 4: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/4.jpg)
Gilead Fellowship 2014• builds on the findings of the LJWG 2013 pilot
projects
• need for comprehensive data collection
• barriers to onward referral along the care pathway
• provide recommendations to address these barriers
![Page 5: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/5.jpg)
Understand the barriers to data collection
![Page 6: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/6.jpg)
Why Data Collection?• variations in infrastructure for collecting data• a lack of baseline information• lower levels of outcome data than expected• need robust data in order to secure action
from commissioners and policy makers. • good practice models to be shared
![Page 7: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/7.jpg)
Unpack barriers in the care pathway to onward referral at
specialist services
![Page 8: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/8.jpg)
What needs to change• only third of London boroughs has a testing-to-
treatment pathway in place • some drug treatment services in the same borough
were unaware of the pathway• variation in practice not only between boroughs, but
also between services in the same borough• barriers to onward referral prevent effective care
pathway
Public Health Report on Commissioning of HCV services in London for People who Inject Drugs, Health Service Journal, 2013
![Page 9: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/9.jpg)
![Page 10: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/10.jpg)
Solutions• set local treatment aspirations and monitor
achievement against them. - example Scottish Action Plan 1.
• replicable data collection systems to monitor patient pathways and assess the impact of interventions
• identify the practical changes needed in hepatitis C care pathways
1. Morris. Tackling hepatitis C: a tale of two countries. Lancet 2011; 377: 1227–1228
![Page 11: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/11.jpg)
Methodology of Service Evaluation• mixed quantitative and qualitative design• a combination of ethnographic observation and
interviews with key personnel • Outcome measure data will be collected
through the service data collection infrastructure
• Qualitative data will be captured through surveys, interviews, focus groups and diary notes.
![Page 12: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/12.jpg)
Who
• drug treatment services• specialist hepatitis treatment service providers• service users • commissioners • two sites in London - well established and effective parts of their services - also areas for improvement
![Page 13: Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWUD in London](https://reader036.vdocument.in/reader036/viewer/2022070411/56649c815503460f94939b11/html5/thumbnails/13.jpg)
Summary• need for better data collection
• unpack the barriers to onward referral
• provide recommendations from the findings
• help implement effective care pathways